Telix Pharmaceuticals Ltd. (AU:TLX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Telix Pharmaceuticals Ltd. has updated its Securities Dealing Policy as of December 2024, aligning with ASX Listing Rule 12.10. This biopharmaceutical company, known for its focus on innovative radiopharmaceuticals, continues to capture attention in the financial markets with its international operations and promising oncology products.
For further insights into AU:TLX stock, check out TipRanks’ Stock Analysis page.
